Insmed (INSM) Change in Cash (2010 - 2026)
Insmed (INSM) recorded quarterly Change in Cash of $71.7 million in Q1 2026, down 59.16% quarter-over-quarter from $175.7 million in Q4 2025, and up 147.27% on a YoY basis from $29.0 million in Q1 2025.
Insmed (INSM) Change in Cash (2010 - 2026) Analysis & Trends
Insmed's Change in Cash history runs 17 years deep, the most recent figure standing at $71.7 million for Q1 2026.
- In Q1 2026, Change in Cash rose 147.27% year-over-year to $71.7 million; the TTM figure through Mar 2026 stood at $178.9 million (up 192.97% YoY), while the FY2025 annual figure was -$44.6 million, down 161.36% from the prior year.
- Change in Cash was $71.7 million for Q1 2026 at Insmed, down from $175.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $881.1 million in Q2 2025 to a low of -$949.6 million in Q3 2025.
- Historically, Change in Cash has averaged -$7.9 million across 5 years, with a median of -$4.7 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Change in Cash tumbled 8603.74% in 2023, then soared 2074.66% in 2024.
- A 5-year view of Change in Cash shows it stood at $659.4 million in 2022, then plunged by 100.72% to -$4.7 million in 2023, then jumped by 2074.66% to $93.6 million in 2024, then soared by 87.74% to $175.7 million in 2025, then tumbled by 59.16% to $71.7 million in 2026.
- The last three Change in Cash figures came in at $71.7 million (Q1 2026), $175.7 million (Q4 2025), and -$949.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -45.97 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 71.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.74 Mn |
| Dec 31, 2025 | 175.68 Mn |
| Sep 30, 2025 | -949.56 Mn |
| Jun 30, 2025 | 881.08 Mn |
| Mar 31, 2025 | -151.78 Mn |
| Dec 31, 2024 | 93.58 Mn |
| Sep 30, 2024 | -785.35 Mn |
| Jun 30, 2024 | 651.07 Mn |
| Mar 31, 2024 | 113.36 Mn |
| Dec 31, 2023 | -4.74 Mn |
| Sep 30, 2023 | -125.77 Mn |
| Jun 30, 2023 | -356.03 Mn |
| Mar 31, 2023 | -105.13 Mn |
| Dec 31, 2022 | 659.40 Mn |
| Sep 30, 2022 | -1.45 Mn |
| Jun 30, 2022 | -99.63 Mn |
| Mar 31, 2022 | -201.08 Mn |
| Dec 31, 2021 | -129.77 Mn |
| Sep 30, 2021 | -81.77 Mn |
| Jun 30, 2021 | 518.58 Mn |